Clinical Significance of Positive Platelet Immunofluorescence Assay in Adult Immune Thrombocytopenia
- 11 April 2014
- journal article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 31 (1) , 85-89
Abstract
Immune thrombocytopenia (ITP) is a relatively common hematologic disorder manifested by low platelet count due to immune-mediated platelet destruction and/or suppression of platelet production. This study aim was to evaluate characteristics and clinical presentation of adult patients with ITP and exploring the clinical value of platelet antibodies assay in proposed cases in Iranian population. In this prospective case series 46 adult patients with ITP and platelet count of 9/L, referred to the Taleghani Medical Center, Tehran, Iran between 2007 and 2009 were evaluated. There were 26 females and 20 males (1.3:1) with mean age of 38.9 ± 19.7 years. The platelet autoantibodies were measured by means of indirect platelet suspension immunofluorescence test. According to our results, 7 patients (15.2 %) displayed a positive platelet antibody assay. There was a significant negative correlation between platelet count and antibody level (r = −0 0.59; p < 0.001). Additionally, a positive correlation between platelet count and patients’ age (r = 0.302; p = 0.042) was detected. 20 patients (56.5 %) were symptomatic at presentation and the most common bleeding signs were petechia, purpura and epistaxis. Results indicated no significant correlation between increased platelet antibody level and bleeding manifestations except for hematuria (r = 0.435; p = 0.02) and epistaxis (r = 0.382; p = 0.015). Disclosure of platelet autoantibodies and the consequential thrombocytopenia associated to some extent but not completely with the propensity to bleed which necessitates more factors to be evaluated.Keywords
This publication has 28 references indexed in Scilit:
- A novel assay for the detection of anti-human platelet antigen antibodies (HPA-1a) based on peptide aptamer technologyHaematologica, 2011
- Predictors of chronic idiopathic thrombocytopenic purpuraPediatric Blood & Cancer, 2010
- The ITP syndrome: pathogenic and clinical diversityBlood, 2009
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Pathogenesis of chronic immune thrombocytopenic purpuraCurrent Opinion in Hematology, 2007
- Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi‐center prospective studyJournal of Thrombosis and Haemostasis, 2006
- T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpuraNature Medicine, 2003
- Advances in the diagnosis of idiopathic thrombocytopenic purpuraSeminars in Hematology, 2000
- A non‐thrombocytopenic bleeding disorder due to an IgG4‐kappa anti‐GPIIb/IIIa autoantibodyBritish Journal of Haematology, 1996
- SIMILARITIES BETWEEN KNOWN ANTIPLATELET ANTIBODIES AND THE FACTOR RESPONSIBLE FOR THROMBOCYTOPENIA IN IDIOPATHIC PURPURA. PHYSIOLOGIC, SEROLOGIC AND ISOTOPIC STUDIESAnnals of the New York Academy of Sciences, 1965